CNS antitumor activity of amivantamab added to osimertinib in EGFR-mutant non–small cell lung cancer with MET amplification as acquired resistance to osimertinib: a case report
International Journal of Cancer Care and Delivery（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要